Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A2, pseudogene (FAM90A2P)
- Target
- FAM90A2P
- Molecular classification
- Other, Pseudogene
01
Overview
Family with sequence similarity 90 member A2, pseudogene (FAM90A2P) is classified as a pseudogene in the human genome, lacking known coding or functional protein product and without established biological functions, molecular activities, or disease roles[3][7]. It is not considered a therapeutic target, and no interacting drugs, biomarkers, or safety concerns are reported in the biomedical literature[3][7].
- Other names
- Putative protein FAM90A2PFAM90A2P
02
Biological functions
Other
03
Disease associations
Other
Beyond the preview
Go deeper on Family with sequence similarity 90 member A2, pseudogene (FAM90A2P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Family with sequence similarity 90 member A2, pseudogene (FAM90A2P).